Diabetes Care 25:370-375, 2002
© 2002 by the American Diabetes Association, Inc.
Pathophysiology/Complications Original Article |
Early Increase of Oxidative Stress and Reduced Antioxidant Defenses in Patients With Uncomplicated Type 1 Diabetes
A case for gender difference
Giampiero Marra, MD1,
Patrizia Cotroneo, MD1,
Dario Pitocco, MD1,
Andrea Manto, MD1,
Mauro A.S. Di Leo, MD1,
Valeria Ruotolo, MD1,
Salvatore Caputo, MD1,
Bruno Giardina, PHD2,
Giovanni Ghirlanda, MD1 and
Stefano A. Santini, MD2
1 Institute of Internal Medicine and Geriatrics, Catholic University School of Medicine, Rome, Italy
2 Institute of Biochemistry and Clinical Biochemistry, Catholic University School of Medicine, Rome, Italy
OBJECTIVEDiabetes increases the risk of coronary heart disease (CHD) to a greater extent in women than in men. We investigated whether type 1 diabetic patients with short duration of disease and without complications have an altered oxidative status and whether there are differences between men and women.
RESEARCH DESIGN AND METHODSWe investigated oxidative status in 29 control subjects and 37 patients with uncomplicated type 1 diabetes with duration of 6 ± 3 years.
RESULTSCompared with control subjects, type 1 diabetic patients had lower total plasma antioxidant capacity (TRAP) (720.3 ± 111.2 vs. 972.5 ± 97.7 µmol/l in men, P < 0.001; 579.8 ± 95.4 vs. 930.1 ± 84.2 in women, P < 0.001), higher lipid hydroperoxide (ROOH) levels (6.4 ± 2.2 vs. 2.0 ± 0.7 µmol/l in men, P < 0.001; 8.1 ± 1.9 vs. 2.2 ± 0.6 in women, P < 0.001), higher total conjugated diene (CD) levels (0.037 ± 0.003 vs. 0.033 ± 0.002 A.U. in men, P < 0.001), lower 246-nm CD levels (0.0032.± 0.0010 vs. 0.0070 ± 0.0012 A.U. in men, P < 0.001; 0.0022 ± 0.0011 vs. 0.0072 ± 0.0014 A.U. in women, P < 0.001), and higher 232-nm CD levels (0.0348 ± 0.0041 vs. 0.0257 ± 0.0022 A.U. in men, P < 0.001; 0.0346 ± 0.0031 vs. 0.0246 ± 0.0074 A.U. in women, P < 0.001). Compared with diabetic men, diabetic women had lower TRAP (P < 0.01), higher ROOH levels (P < 0.01), and lower 246-nm CD levels (P < 0.05). Plasma concentration of uric acid was significantly lower in patients with type 1 diabetes than in control subjects (3.3 ± 0.3 vs. 4.3 ± 0.2 mg/dl; P = 0.009) with a significant difference between women and men with type 1 diabetes (2.6 ± 0.3 vs. 3.9 ± 0.3, respectively; P = 0.009).
CONCLUSIONSOur findings suggest that reduced antioxidant activity and increased oxidative stress occur early after the diagnosis of type 1 diabetes, especially in women, and this might explain, at least in part, the increased susceptibility of diabetic women to cardiovascular complications.
Abbreviations: ABTS, 2,2'-azinobis-(3-ethylbenzothiazoline-6-sulphonic acid) CD, conjugated diene CHD, coronary heart disease ROOH, hydroperoxide TPP, triphenylphosphine TRAP, total plasma antioxidant capacity

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
W. W. Chance, C. Rhee, C. Yilmaz, D. M. Dane, M. L. Pruneda, P. Raskin, and C. C.W. Hsia
Diminished Alveolar Microvascular Reserves in Type 2 Diabetes Reflect Systemic Microangiopathy
Diabetes Care,
August 1, 2008;
31(8):
1596 - 1601.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. F. Walter, R. F. Jacob, R. E. Bjork, B. Jeffers, J. Buch, Y. Mizuno, R. P. Mason, and on behalf of the PREVENT Investigators
Circulating Lipid Hydroperoxides Predict Cardiovascular Events in Patients With Stable Coronary Artery Disease: The PREVENT Study
J. Am. Coll. Cardiol.,
March 25, 2008;
51(12):
1196 - 1202.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y Shimoni, D Hunt, M Chuang, K. Y Chen, G Kargacin, and D. L Severson
Modulation of potassium currents by angiotensin and oxidative stress in cardiac cells from the diabetic rat
J. Physiol.,
August 15, 2005;
567(1):
177 - 190.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Fauconnier, J. T. Lanner, S.-J. Zhang, P. Tavi, J. D. Bruton, A. Katz, and H. Westerblad
Insulin and Inositol 1,4,5-Trisphosphate Trigger Abnormal Cytosolic Ca2+ Transients and Reveal Mitochondrial Ca2+ Handling Defects in Cardiomyocytes of ob/ob Mice
Diabetes,
August 1, 2005;
54(8):
2375 - 2381.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Ceriello, L. Piconi, L. Quagliaro, Y. Wang, C. A. Schnabel, J. A. Ruggles, M. A. Gloster, D. G. Maggs, and C. Weyer
Effects of Pramlintide on Postprandial Glucose Excursions and Measures of Oxidative Stress in Patients With Type 1 Diabetes
Diabetes Care,
March 1, 2005;
28(3):
632 - 637.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Dragsted, G Ravn-Haren, M Hansen, M Kall, V Breinholt, J Jakobsen, S. Rasmussen, A Pedersen, B Sandstrom, A Hermetter, et al.
Reply to M Serafini et al
Am. J. Clinical Nutrition,
February 1, 2005;
81(2):
532 - 534.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Vincent, J. W. Russell, P. Low, and E. L. Feldman
Oxidative Stress in the Pathogenesis of Diabetic Neuropathy
Endocr. Rev.,
August 1, 2004;
25(4):
612 - 628.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Ye, N. S. Metreveli, R. V. Donthi, S. Xia, M. Xu, E. C. Carlson, and P. N. Epstein
Catalase Protects Cardiomyocyte Function in Models of Type 1 and Type 2 Diabetes
Diabetes,
May 1, 2004;
53(5):
1336 - 1343.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Ye, N. S. Metreveli, J. Ren, and P. N. Epstein
Metallothionein Prevents Diabetes-Induced Deficits in Cardiomyocytes by Inhibiting Reactive Oxygen Species Production
Diabetes,
March 1, 2003;
52(3):
777 - 783.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Diabetes Association.
|
|
| |
|